News

Celebrating Cancer Immunotherapy: SITC's 40th Anniversary Honors

Celebrating Cancer Immunotherapy: SITC's 40th Anniversary Honors

Celebrating a Milestone in Cancer Treatment

The Society for Immunotherapy of Cancer (SITC) is excited to celebrate its 40th anniversary by recognizing the extraordinary contributions made to the field of cancer immunotherapy. This significant occasion serves not only as a reflection of the past but also as a beacon of hope for the future of cancer treatment. The SITC takes pride in honoring exceptional individuals and institutions who have notably advanced the world of immuno-oncology.

A Legacy of Advancement

Since its establishment in 1984, the SITC has been dedicated to advancing immunotherapy through comprehensive education, groundbreaking research, and collaboration among professionals in the field. The organization has pioneered numerous initiatives that facilitate scientific understanding and clinical application of immunotherapies, which play an essential role in improving patient outcomes.

Recognizing Leaders in the Field

As part of its anniversary celebrations, SITC has introduced special Anniversary Awards. These awards highlight the achievements and dedication of those who have significantly influenced cancer immunotherapy. Honorees include pioneers and visionaries who have displayed relentless commitment to changing the landscape of cancer care. The awards are a tribute to the impactful contributions that have led to lifesaving treatments for patients globally.

Announcing the Award Recipients

This year’s recipients of the 40th Anniversary Awards exemplify the highest standards of dedication and innovation:

Innovation Award
Peter Marks, MD, PhD

Martin "Mac" Cheever Distinguished Service Awards
Olivera Finn, PhD, FAIO (University of Pittsburgh)
John M. Kirkwood, MD (UPMC Hillman Cancer Center)

Team Science Award
University of Wisconsin Carbone Cancer Center
Mark Albertini, MD
Christian M. Capitini, MD
Douglas G. McNeel, MD, PhD
Zachary Morris, MD, PhD
Rebecca Richards, MD, PhD
Quaovi Sodji, MD, PhD
Paul M. Sondel, MD, PhD

Collaboration Award
Andres Salazar, MD (Oncovir, Inc.)

International Neoadjuvant Melanoma Consortium (INMC)
Elizabeth Burton, PhD, MBA (The University of Texas MD Anderson Cancer Center)
Rodabe Amaria, MD (The University of Texas MD Anderson Cancer Center)
Paolo Ascierto, MD (Istituto Nazionale Tumori IRCCS Fondazione G. Pascale)
Christian U. Blank, MD (The Netherlands Cancer Institute)
Georgina V. Long, AO (The Melanoma Institute of Australia)
Alexander M. Menzies, FRACP, PhD (The Melanoma Institute of Australia)
Richard Scolyer, AO (The Melanoma Institute of Australia)
Hussein Tawbi, MD, PhD (The University of Texas MD Anderson Cancer Center)
Michael Tetzlaff, MD, PhD (University of California San Francisco)
Alex van Akkooi, MD, PhD, FRACS (The Melanoma Institute of Australia)
Jennifer Wargo, MD (The University of Texas MD Anderson Cancer Center)

Champion of SITC Awards
Paolo Antonio Ascierto, MD (Istituto Nazionale Tumori IRCCS Fondazione G. Pascale)
Michael B. Atkins, MD, FAIO (Georgetown Lombardi Comprehensive Cancer Center)
Tullia C. Bruno, PhD (University of Pittsburgh)
Lisa H. Butterfield, PhD (Merck Research Labs)
Christian M. Capitini, MD (University of Wisconsin-Madison)
Alessandra Cesano, MD PhD (Summit Tx)
Daniel S. Chen, MD, PhD (Synthetic Design Lab, Inc.)
Mary L. 'Nora' Disis, MD, FACP (University of Washington)
Robert L. Ferris, MD PhD (University of North Carolina)
Henry Diego Patty Flores, PhD (CMNYR El ALTO ABEN)
Bernard A. Fox, PhD (Earle A. Chiles Research Institute, Providence Cancer Institute)
Jerome Galon, PhD (INSERM)
Thomas F. Gajewski, MD, PhD, FAIO (University of Chicago)
James L. Gulley, MD, PhD, FACP (National Cancer Institute)
Kristen M. Hege, MD (Board Member, Mersana, Adaptimmune, Kelonia, KSQ and EvolveImmune)
F. Stephen Hodi, MD (Dana-Farber Cancer Institute)
Patrick Hwu, MD (Moffitt Cancer Center)
Howard L. Kaufman, MD, FACS (Ankyra Therapeutics/Massachusetts General Hospital)
Samir N. Khleif, MD (Georgiamune, LLC)
John M. Kirkwood, MD (UPMC Hillman Cancer Center)
Michael T. Lotze, MD, FACS (University of Pittsburgh Medical Center)
Jason J. Luke, MD, FACP, FASCO (Strand Therapeutics)
Cristina Maccalli, PhD (Sidra Medicine)
Kim A. Margolin, MD (St. John's Cancer Institute)
Francesco Marincola, MD (Sonata Therapeutics)
Marcela V. Maus, MD, PhD (Massachusetts General Hospital)
Douglas G. McNeel, MD, PhD (University of Wisconsin-Madison)
Chrystal M. Paulos, PhD (Winship Cancer Institute at Emory University)
William L. Redmond, PhD (Earle A. Chiles Research Institute)
Pedro J. Romero, MD (Novigenix)
Kimberly A. Shafer-Weaver, PhD, MBA (Merck & Co.)
Craig L. Slingluff Jr., MD (University of Virginia School of Medicine)
Ryan J. Sullivan, MD (Harvard Medical School, Massachusetts General Hospital)
Mario Sznol, MD (Yale University Department of Medical Oncology: Yale Cancer Center)
Walter J. Urba, MD, PhD (Earle A. Chiles Research Institute)
Jon M. Wigginton, MD (Bright Peak Therapeutics)
Jedd D. Wolchok, MD, PhD, FAIO (Weill Cornell Medicine)

Looking Ahead: The Future of Immunotherapy

The recipients of these prestigious awards will be recognized during SITC's 40th Anniversary Annual Meeting, scheduled for Nov. 5-9, 2025. This gathering at the Gaylord National Resort & Convention Center promises to be a remarkable event celebrating innovation and collaboration in the field of cancer immunotherapy.

About SITC

Established in 1984, the Society for Immunotherapy of Cancer (SITC) is a nonprofit organization consisting of medical professionals devoted to enhancing cancer patient outcomes by advancing cancer immunotherapy and tumor immunology. SITC’s members include prominent basic and translational scientists, healthcare professionals, government officials, and industry experts. Through its educational programs and collaborative efforts, SITC aims to make the word 'cure' a tangible reality for cancer patients worldwide.

Frequently Asked Questions

What is the Society for Immunotherapy of Cancer?

The Society for Immunotherapy of Cancer (SITC) is a nonprofit organization aimed at advancing cancer immunotherapy and improving patient outcomes.

Who received the Innovation Award in 2025?

Peter Marks, MD, PhD, received the Innovation Award at the SITC's 40th Anniversary event.

When will the 40th Anniversary Annual Meeting take place?

The annual meeting is scheduled for Nov. 5-9, 2025, at the Gaylord National Resort & Convention Center.

What is the vision of SITC for the future?

SITC aims to enhance patient outcomes and ultimately make immunotherapy cures a standard reality for cancer patients everywhere.

How has SITC contributed to the field of immunotherapy?

SITC fosters scientific exchange and collaboration, providing education and resources to advance the field of cancer immunotherapy.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Luxury Villa Cashback Offers Entice Travelers in November

Updated Category News Views 134

A November Bonanza for Villa Bookings Who doesn't love having a few extra bucks in their pocket, especially when they come with the allure of luxury travel? Villas of Distinction is rolling out what they call a 'November Cashback Offer,' and for those with the wallet—and wanderlust—to match, it could be a tempting proposition. Hanging the bait of up to $2,000 cashback...

Continue Reading
Apotex Enters U.S. Market with Axitinib Tablets Launch

Updated Category News Views 114

Apotex's Bold Move: Axitinib Tablets Hit the U.S. Market Apotex is shaking things up in the pharma world by launching the first generic version of Axitinib Tablets in the U.S., aimed at treating advanced renal cell carcinoma (RCC) when previous treatments have fallen flat. This isn't just another dance with the red tape—it's a major step for Apotex, flexing their muscle...

Continue Reading
Ross Pools Joins Forces with Florida Panthers in 2026

Updated Category News Views 64

An Unlikely Team-Up: Pools and Hockey Well, here's one for the books: a South Florida pool company hitching its wagon to an NHL team. Ross Pools, the folks who’ve been carving out backyard oases in the sizzling Florida sun for over two decades, are now officially aligned with the Florida Panthers. Yeah, the same Panthers that snatched the Stanley Cup not once but twice...

Continue Reading
TCL Unveils Black Friday Steals on Smart Devices

Updated Category News Views 148

TCL's Big Move This Holiday Season When was the last time you saw a deal that actually made you stop and check your wallet? Well, TCL is giving you a reason to dig deep this Black Friday and Cyber Monday. They're slashing prices across smartphones and tablets, trying to elbow their way into your shopping cart with discounts up to $150. Now that's the kind of aggressive...

Continue Reading
LinkedIn Shines: Brands Face Social Media Slump

Updated Category News Views 77

LinkedIn: The Unsung Hero in Social Platforms In a world where social media seems to be as unpredictable as the stock market, LinkedIn is surprisingly holding the line. According to Vista Social's 2027 report, LinkedIn proudly boasts the highest median engagement rate among brand pages at 5.8%. Now, in the wild west of social media, where reach is getting tougher to snag,...

Continue Reading
Visit W&H at the Greater New York Dental Meeting

Updated Category News Views 112

Why This Event Matters for Dental Professionals Stroll through any convention center halls and you can see the future unfolding right in front of you. The upcoming Greater New York Dental Meeting is no different, especially with W&H Group setting up shop. For any dental professionals out there, this is your chance to get your hands on some real-deal tech that might just...

Continue Reading
Neil deGrasse Tyson Headlines HIMSS27 with Cosmic Insights

Updated Category News Views 188

celebrated science communicator, is set to close out the HIMSS27 conference with a keynote that's bound to leave a lasting impression. It's a fitting intersection of stars and stethoscopes, as the astrophysicist brings his expansive lens to the nitty-gritty of healthcare innovation. Splicing Science with Storytelling Folks, this ain't your standard healthcare gathering....

Continue Reading
Thread AI Joins Microsoft Pegasus: Big AI Leap

Updated Category News Views 26

Thread AI Leaps Ahead with Microsoft Partnership There's excitement in the air as Thread AI joins forces with Microsoft by entering the exclusive Pegasus Program. In the ever-evolving world of AI, making a splash this big doesn't happen every day. People in the tech alley are buzzing, and it looks like Thread AI is ready to rumble on a larger stage—much like a scrappy...

Continue Reading
Epic Legal Battle Yields $63M Verdict Against Chevron

Updated Category News Views 359

A David vs. Goliath Showdown in Court How's this for a courtroom drama? Picture eight lawyers taking on Chevron over a toxic pit buried beneath an unsuspecting family's home. These folks at Ernst Law Group and Trial Lawyers for Justice tackled Union Oil (now Chevron) and bagged a staggering $63 million for their client. This ain't your run-of-the-mill legal squabble; it's...

Continue Reading
Tackling the Industrialized Beast of Insurance Fraud

Updated Category News Views 86

Stepping Up the Fraud Fight This year's emerging fraud trends are taking the term 'organized crime' to new heights, and it's painting a bullseye on the insurance industry. The National Insurance Crime Bureau (NICB) just laid out how fraud isn't just a series of isolated scams anymore—it's an industrial-scale racket. As they spotlight during International Fraud Awareness...

Continue Reading

Top 5 Most Recently Viewed Articles

Evogene Partners with Academic Leader to Combat Metabolic Disorders

Updated Category News Views 174

Evogene's Innovative Collaboration Evogene Ltd. (NASDAQ: EVGN) has entered into an exciting partnership with Professor Ehud Gazit from Tel Aviv University to develop innovative therapeutics aimed at metabolic diseases. Understanding Metabolic Diseases Metabolic diseases often arise from the inability of the body to break down specific metabolites. This inability can lead...

Continue Reading
Farasis Energy's Rise in Solid-State Battery Rankings Explained

Updated Category News Views 505

Farasis Energy's Notable Achievement in Battery Technology Recently, Farasis Energy gained recognition as a leading contender in the 2024 China Solid-State Battery Competitiveness Rankings, marking a significant milestone in the company's journey. As a global frontrunner in electric vehicle (EV) battery solutions, Farasis Energy has established robust partnerships with...

Continue Reading
Building a Reliable Future with Weilliptic's Advanced AI

Updated Category News Views 310

Weilliptic: Pioneering Autonomous and Trustworthy AI In the rapidly evolving landscape of technology, Avinash Lakshman, a serial entrepreneur renowned for creating Amazon Dynamo and Apache Cassandra, is leading the charge towards a new foundational infrastructure that merges AI and blockchain into a cohesive and verifiable framework. This innovative platform, known as...

Continue Reading
Navigating Investor Rights: Aehr Test Systems Case Insights

Updated Category News Views 169

Aehr Test Systems Investor Rights and Securities Fraud Lawsuit Investors in Aehr Test Systems (NASDAQ: AEHR) find themselves at a critical juncture. The Rosen Law Firm, renowned for its advocacy on behalf of investors, has issued important reminders regarding a securities fraud lawsuit that centers on Aehr Test Systems. Understanding the Class Period The timeline for this...

Continue Reading
Understanding Andersons' Earnings and Market Performance Insights

Updated Category News Views 276

Anticipating Earnings from Andersons Inc Andersons Inc (NASDAQ: ANDE) is gearing up to share its quarterly earnings report soon. This announcement is of considerable interest to both existing shareholders and potential investors. It's vital to stay informed about what to expect before the company reveals its financial results. Projected Earnings and Market Sentiments...

Continue Reading